drugset / Trial / NCT01001520

Neural Substrates in Nicotine Withdrawal

NCT01001520

RandomizedCrossoverDouble-blindTreatment

Summary

This study will test the hypothesis that a medication called tolcapone (Brand Name: Tasmar) will help reduce cognitive problems that smokers experience when they quit. This study will also determine whether the benefits of this medication differ depending on a smokers' genetic background.

Timeline

Start
2010-01
Primary completion
2012-10
Completion
2012-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tolcapone Unknown 200 mg Oral

Indications